HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christian Buske Selected Research

Atrial Fibrillation

12/2020Zanubrutinib for the treatment of MYD88 wild-type Waldenström macroglobulinemia: a substudy of the phase 3 ASPEN trial.
10/2020A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study.
6/2018Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström's Macroglobulinemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christian Buske Research Topics

Disease

19Neoplasms (Cancer)
01/2022 - 01/2005
16Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 02/2003
16Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2022 - 01/2016
13Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2022 - 07/2005
10Leukemia
06/2017 - 01/2004
9Lymphoma (Lymphomas)
01/2022 - 01/2005
7B-Cell Lymphoma (Lymphoma, B Cell)
06/2021 - 10/2007
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
08/2013 - 01/2005
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2022 - 11/2009
3Atrial Fibrillation
12/2020 - 06/2018
3Neutropenia
10/2020 - 04/2009
2Hemorrhage
12/2020 - 10/2020
2Hypertension (High Blood Pressure)
12/2020 - 06/2018
2Diarrhea
10/2020 - 06/2018
2Rheumatoid Arthritis
11/2018 - 08/2017
2Hematologic Neoplasms (Hematological Malignancy)
05/2017 - 03/2011
2Hematologic Diseases (Blood Diseases)
06/2013 - 06/2003
1Thrombocytopenia (Thrombopenia)
12/2022
1Disease Progression
02/2021
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2021
1COVID-19
01/2021
1Pneumonia (Pneumonitis)
10/2020
1Contusions
10/2020
1Edema (Dropsy)
10/2020
1Infections
10/2020
1Spasm (Spasms)
10/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2020
1Lung Neoplasms (Lung Cancer)
07/2020
1Iron Overload
01/2020
1Carcinogenesis
01/2019
1Arthralgia (Joint Pain)
06/2018
1Nausea
06/2018
1Body Weight (Weight, Body)
01/2018
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
11/2017
1Paraproteinemias (Monoclonal Gammopathy)
11/2017
1Anemia
02/2017
1Phototoxic Dermatitis (Phototoxicity)
01/2017
1Photosensitivity Disorders (Photodermatitis)
01/2017

Drug/Important Bio-Agent (IBA)

19Rituximab (Mabthera)FDA Link
01/2022 - 01/2005
11ibrutinibIBA
01/2022 - 06/2018
9Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2008
6Monoclonal AntibodiesIBA
06/2021 - 01/2005
5CT-P10IBA
01/2022 - 05/2017
5Agammaglobulinaemia Tyrosine KinaseIBA
02/2021 - 09/2018
5Biosimilar PharmaceuticalsIBA
01/2021 - 05/2017
4Biological ProductsIBA
01/2022 - 08/2011
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 09/2006
3obinutuzumabIBA
12/2022 - 05/2020
3Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 09/2006
3Immunoglobulin M (IgM)IBA
01/2021 - 11/2017
3Prednisone (Sone)FDA LinkGeneric
01/2021 - 09/2006
3zanubrutinibIBA
12/2020 - 09/2018
3MicroRNAs (MicroRNA)IBA
01/2020 - 11/2009
3DNA (Deoxyribonucleic Acid)IBA
11/2017 - 07/2009
3AntibodiesIBA
11/2006 - 01/2005
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2018
2Peptides (Polypeptides)IBA
02/2021 - 01/2020
2RutheniumIBA
01/2020 - 01/2017
2Photosensitizing Agents (Photosensitizers)IBA
01/2020 - 01/2017
2Cytarabine (Cytosar-U)FDA LinkGeneric
12/2018 - 04/2009
2Doxorubicin (Adriamycin)FDA LinkGeneric
06/2013 - 09/2006
2Transcription Factors (Transcription Factor)IBA
03/2013 - 08/2005
2Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
11/2009 - 11/2006
1venetoclaxIBA
12/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1atezolizumabIBA
01/2022
1copanlisibIBA
06/2021
15-hydroxymethylcytosineIBA
01/2021
1EnzymesIBA
01/2021
1histone H3 trimethyl Lys4IBA
01/2021
1thrombin receptor peptide SFLLRNPIBA
01/2021
1olaparibIBA
01/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021
1P-SelectinIBA
01/2021
1Enoxaparin (Lovenox)FDA LinkGeneric
12/2020
1Circulating Tumor DNAIBA
07/2020
1acalabrutinibIBA
02/2020
1Somatostatin Receptors (Somatostatin Receptor)IBA
01/2020
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2020
1IronIBA
01/2020
1Coordination ComplexesIBA
01/2020
16-bromo-2-naphthyl sulfate (BNS)IBA
01/2019
1Mitoxantrone (Novantrone)FDA LinkGeneric
12/2018
1Alkylating AgentsIBA
10/2018
1GlucocorticoidsIBA
01/2018
1Discoidin Domain ReceptorsIBA
11/2017
1protein phosphatase 4IBA
11/2017
1Histones (Histone)IBA
11/2017
1Antineoplastic Agents (Antineoplastics)IBA
11/2017
1Silicon Dioxide (Silica)FDA LinkGeneric
06/2017
1Blood Proteins (Serum Proteins)IBA
06/2017
11-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2017

Therapy/Procedure

21Therapeutics
12/2022 - 01/2005
6Drug Therapy (Chemotherapy)
11/2017 - 01/2005
6Transplantation
12/2016 - 06/2003
2Stem Cell Transplantation
10/2007 - 09/2006
1Critical Care (Surgical Intensive Care)
01/2021
1Biological Therapy
10/2019
1Intravenous Infusions
08/2017
1Photochemotherapy (Photodynamic Therapy)
01/2017